{"count": 1, "results": [{"_id": "16639331", "pmid": 16639331, "title": "Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.", "journal": "Neurosurgery", "authors": ["McGirt MJ", "Pradilla G", "Legnani FG", "Thai QA", "Recinos PF", "Tamargo RJ", "Clatterbuck RE"], "date": "2006-05-01T00:00:00Z", "doi": "10.1227/01.NEU.0000210262.67628.7E", "meta_date_publication": "2006 May", "meta_volume": "58", "meta_issue": "5", "meta_pages": "945-51; discussion 945-51", "score": 50053.18, "text_hl": "CONCLUSION: Subcutaneous administration of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ after the onset of @DISEASE_Subarachnoid_Hemorrhage @DISEASE_MESH:D013345 @@@SAH@@@ attenuates perivascular granulocyte migration and ameliorates @<m>DISEASE_Coronary_Vasospasm</m> @DISEASE_MESH:D003329 @@@basilar artery vasospasm@@@ after experimental @DISEASE_Subarachnoid_Hemorrhage @DISEASE_MESH:D013345 @@@SAH@@@ in @SPECIES_9986 @@@rabbits@@@. 5-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, such as @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, may potentially serve as agents in the prevention of @DISEASE_Vasospasm_Intracranial @DISEASE_MESH:D020301 @@@cerebral vasospasm@@@ after @DISEASE_Subarachnoid_Hemorrhage @DISEASE_MESH:D013345 @@@SAH@@@.", "citations": {"NLM": "McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, Clatterbuck RE. Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm. Neurosurgery. 2006 May;58(5):945-51; discussion 945-51. PMID: 16639331", "BibTeX": "@article{16639331, title={Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.}, author={McGirt MJ and Pradilla G and Legnani FG and Thai QA and Recinos PF and Tamargo RJ and Clatterbuck RE}, journal={Neurosurgery}, volume={58}, number={5}, pages={945-51; discussion 945-51}}"}}]}